Guardant Health partners with Quest for blood-based cancer screening
Go back to Guardant Health partners with Quest for blood-based cancer screening| Quest Diagnostics (NYSE: DGX) | Delayed: 203.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $203.83 | 52 Week High | $86.85 | |||
| Open | $203.83 | 52 Week Low | $59.66 | |||
| Day High | $203.83 | P/E | 38.39 | |||
| Day Low | $203.83 | EPS | $5.31 | |||
| Volume | 89 | |||||
| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 130.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.90 | 52 Week High | $5.84 | |||
| Open | $130.90 | 52 Week Low | $5.49 | |||
| Day High | $130.90 | P/E | N/A | |||
| Day Low | $130.90 | EPS | $0.00 | |||
| Volume | 165 | |||||
